• Lapidot Compounding Center dedicated MOH approved facility is in accordance with stringent regulatory sterility standards, reducing the risk encountered in local hospital preparations.

    Our GPP (good preparation practices) certificate, is under the guidelines of Procedure No. 135 “Proper Preparation Conditions at the Pharmacy – High-Risk preparations: Sterile and Aseptic preparations” of the Israeli Ministry of Health.

    Lapidot Compounding Center established in collaboration with B.Braun Group, one of the world's leading, highest quality sterile liquid dosage form and related medical device providers in the field.

    The new state of the art Lapidot Compounding Center utilizes B.Braun Group's extensive product manufacturing knowledge and experience.

    Lapidot Compounding Center benefits the advanced GMP/GDP infrastructure and extensive experience of the Lapidot Group in top logistical quality distribution of pharmaceuticals and medical supplies.

    Lapidot Compounding Center meets the most stringent standards in the field of pharmaceutical preparations. Our expert team are now providing top quality solutions and products to the Israel health centers and home based patients.